GÜLDEN ANATACA
GÜLDEN ANATACA
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome | 46,XX disorder of sex development, Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hyperandrogenism, Insulin Resistance, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Abnormalities, Urogenital Diseases, adrenogenital syndrome, disorder of sexual differentiation, endocrine system disorder, female reproductive system disorder, glucose metabolism disease, gonadal disorder, hyperinsulinism, metabolic disease, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome | Not yet recruiting | Not stated | 2026-07-30 | NCT07736079 | |
| Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy? | Diabetes Complications, Nutritional and Metabolic Diseases, diabetes mellitus, diabetic neuropathy, endocrine system disorder, glucose metabolism disease, metabolic disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, type 2 diabetes mellitus | Not yet recruiting | Not stated | 2026-07-29 | NCT07734597 | |
| Evaluation of Neuregulin-4 (NRG4) Levels in Obese and Non-Obese Patients With Type 2 Diabetes Mellitus | Body Weight, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Not yet recruiting | Not stated | 2026-07-29 | NCT07734558 |